3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
CNS
1
Conditions
Sleep Initiation and Maintenance Disorders
30
Neoplasms
22
Breast Neoplasms
20
Anxiety Disorders
13
Depression
12
Prostatic Neoplasms
8
Fatigue
8
Motor Activity
4
Lymphoma
4
Lung Neoplasms
4
Weight Loss
3
Uterine Cervical Neoplasms
3
Ovarian Neoplasms
3
Melanoma
3
Colorectal Neoplasms
3
Chronic Pain
3
Smoking Cessation
2
Sleep Wake Disorders
2
Pain
2
Overweight
2
Obesity
2
Nervous System Diseases
2
Multiple Myeloma
2
Lymphoma, Follicular
2
Glioma
2
Glioblastoma
2
Cognitive Dysfunction
2
Carcinoma, Non-Small-Cell Lung
2
Weight Gain
1
Uterine Neoplasms
1
Interventions
Radiosurgery
114
Temozolomide
104
Bevacizumab
71
Radiotherapy
67
Magnetic Resonance Spectroscopy
67
Carboplatin
29
pembrolizumab
28
Irinotecan
26
Surgical Procedures, Operative
25
Radiation
23
Nivolumab
23
Etoposide
22
Magnetic Resonance Imaging
21
Ipilimumab
21
Erlotinib Hydrochloride
21
Cyclophosphamide
21
Surveys and Questionnaires
19
Aminolevulinic Acid
18
Specimen Handling
16
Pemetrexed
16
Mental Status and Dementia Tests
16
Cisplatin
16
Carmustine
15
Topotecan
14
Trastuzumab
13
Saline Solution
12
Neuropsychological Tests
12
Gefitinib
11
Filgrastim
11
Drug Therapy
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Brain Neoplasms
×
Cognitive Behavioral Therapy
×
Clear all
NCT06439420
2025-10-01
CBT-I in PBT
Virginia Commonwealth University
Phase 2
Completed
70 enrolled